SP Thoracic IDE Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 20, 2022

Primary Completion Date

June 16, 2023

Study Completion Date

July 31, 2028

Conditions
Primary Lung CancerBenign Lung DiseaseThymomaMyasthenia Gravis
Interventions
DEVICE

Robotic-Assisted Surgery

da Vinci SP Surgical System, instruments, and accessories in pulmonary lobectomy and thymectomy for benign and malignant disease.

Trial Locations (6)

10016

NYU Langone Health, New York

10065

Memorial Sloan Kettering Cancer Center, New York

27710

Duke University Hospital, Durham

77030

MD Anderson Cancer Center, Houston

90048

Cedars-Sinai Medical Center, Los Angeles

02115

Brigham and Women's Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Intuitive Surgical

INDUSTRY

NCT05150210 - SP Thoracic IDE Study | Biotech Hunter | Biotech Hunter